In contrast to our observations, these studies, which were carried out with U87-MG and LN229 cell lines, showed that LINC00152 knockdown effectively suppressed malignant tumor behaviors including migration, invasion, proliferation, EMT, and therefore, may serve as a therapeutic target for glioblastoma treatment (Fig. 4)15,17. This evidence concerns the gene CYTOR and glioblastoma.